Clinical updates, including trial initiations, enrollment status and data readouts and publications: Corcept, Duality, Immunic, Maia, Novartis, Regenxbio.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anaptysbio, Ascletis, Atyr, Corvus, Halo, Immix, Innovent, Insilico, J&J, Moleculin, Sionna, Tolremo, Vasa.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amicus, Ascentage, Beyondspring, Cardiff Oncology, Corcept, Experimental Drug Development Centre, Genmab, Ichnos Glenmark, Immuneoncia, Immunitybio, Imunon, Innovent, Jazz, Johnson & Johnson, Kura, Kyowa Kirin, Nasus, OSE, PDS, Perspective, Remegen, Roche, Traws, Vigil Neuroscience.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amber Implants, Freenome, Precede Biosciences, Tactile.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actuate, In8bio, Kalvista, Kymera, Lyra, Nervgen, Novartis, Opus Genetics, Pharvaris, Regeneron, Replimune, Reviva, Teva, Viatris, Vera, Verastem, Xilio.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Biolinerx, Corestemchemon, GC Pharma, Immutep, Innovent.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Avadel, Biolinerx, Enterome, Faron, GC Biopharma, Genentech, Merck, Pfizer, Regeneron, Roche, Sanofi, Summit.